Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

TADAWUL/9572 stock hub

TADAWUL/9572 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TADAWUL/9572is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

49M

Saudi Stock Exchange

Market data

Price

Recent price action with selectable time range.

TADAWUL/9572TADAWUL/9572

—

Loading chart…

In the news

Latest news · TADAWUL/9572

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E59.8

P25 n/aP50 n/aP75 n/a

ROE3.6

P25 n/aP50 n/aP75 n/a

ROIC3.3

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TADAWUL/9572 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

203

Groups with data

Currency

SAR

Showing 203 of 203 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Saudi Arabia
Country code	SA
Enterprise value	SAR 60.6M
Exchange	Saudi Stock Exchange
Financial currency	SAR
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	SA15R0E4LI18
Last refreshed	2026-05-10
Market cap	SAR 49M
Price	SAR 32.02
Price currency	SAR
Sector	Healthcare
Sic	5047
Symbol	tadawul/9572
Website	https://www.razimed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.67%
EV Earnings	73.97x
EV/EBIT	39.97x
EV/EBITDA	11.85x
EV/FCF	15.75x
EV/Sales	0.81x
FCF yield	7.85%
P/B ratio	2.09x
P/E ratio	59.8x
P/S ratio	0.66x
PE Ratio3 Y	291.1x
PE Ratio5 Y	301.45x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	2.04%
EBITDA Margin	4.39%
FCF margin	5.17%
Gross margin	25.73%
Gross Profit	SAR 19.1M
Gross Profit Growth	10.56%
Gross Profit Growth Q	22.26%
Gross Profit Growth3 Y	5.42%
Gross Profit Growth5 Y	1.2%
Net Income	SAR 819,462
Net Income Growth	365.96%
Net Income Growth Q	324.46%
Net Income Growth Quarters	3%
Net Income Growth Years	1%
Net Income Growth3 Y	108.99%
Net Income Growth5 Y	-16.68%
Pretax Margin	1.44%
Profit Margin	1.1%
Profitable Years	5
ROA	2.01
ROCE	4.55
ROE	3.55
ROIC	3.31
Roic5y	4.85

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-27.9%
EPS Growth	366
EPS Growth Q	324.5
EPS Growth Quarters	3
EPS Growth Years	1
EPS Growth3 Y	109
EPS Growth5 Y	-16.68
FCF Growth	249.88%
FCF Growth5 Y	12.38%
OCF Growth	17.45%
OCF Growth Q	149.78%
OCF Growth3 Y	-1.32%
OCF Growth5 Y	13.41%
Revenue Growth	21.24x
Revenue Growth Q	34x
Revenue Growth Quarters	2x
Revenue Growth Years	4x
Revenue Growth3 Y	6.26x
Revenue Growth5 Y	4.79x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	SAR 1.58
Assets	SAR 53.3M
Cash	SAR 312,534
Current Assets	SAR 29.3M
Current Liabilities	SAR 20M
Debt	SAR 11.9M
Debt EBITDA	SAR 2.33
Debt Equity	SAR 0.51
Debt FCF	SAR 3.1
Equity	SAR 23.5M
Interest Coverage	1.84
Liabilities	SAR 29.8M
Long Term Assets	SAR 24M
Long Term Liabilities	SAR 9.9M
Net Cash	SAR -11.6M
Net Cash By Market Cap	SAR -23.69
Net Debt EBITDA	SAR 3.56
Net Debt Equity	SAR 0.49
Net Debt FCF	SAR 3.02
Tangible Book Value	SAR 23.3M
Tangible Book Value Per Share	SAR 15.33
WACC	6.43

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.47
Inventory Turnover	2.63
Net Working Capital	SAR 12.3M
Quick ratio	0.24
Working Capital	SAR 9.4M
Working Capital Turnover	SAR 7.44

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend per share	SAR 1.59
Dividend Yield	4.96%
Last Dividend	SAR 0.39

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-27.88%
200-day SMA	33.27
50-day SMA	29.34
50-day SMA vs 200-day SMA	50under200
All Time High	88.9
All Time High Change	-63.98%
All Time High Date	2023-07-10
All Time Low	25.1
All Time Low Change	27.57%
All Time Low Date	2026-03-08
ATR	1.18
Beta	0.45
Beta1y	0.17
Beta2y	0.04
Ch YTD	4.98
High	32.02
High52	49.7
High52 Date	2025-06-11
High52ch	-35.57%
Low	32.02
Low52	25.1
Low52 Date	2026-03-08
Low52ch	27.57%
Ma50ch	9.12%
Price vs 200-day SMA	-3.75%
RSI	57.23
RSI Monthly	43.46
RSI Weekly	0
Sharpe ratio	-0.44x
Sortino ratio	-0.53
Total Return	4.96%
Tr YTD	4.98
Tr1m	10.41%
Tr1w	2.17%
Tr3m	6.73%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	SAR 1.5M
Operating Income Growth	7.17
Operating Income Growth Q	490.9
Operating Income Growth3 Y	24.11
Operating Income Growth5 Y	-11.49
Operating margin	2.04

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	631,218%
Net Borrowing	-3,924,264
Shares Insiders	58.47%
Shares Out	1,520,000
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	SAR 3.8M
Average Volume	6,209.35x
Bv Per Share	15.46
CAPEX	SAR -2M
Ch1m	10.41
Ch1w	2.17
Ch1y	-27.88
Ch3m	6.73
Ch6m	-7.19
Change	0%
Change From Open	0
Close	32.02
Days Gap	0
Depreciation Amortization	1,749,013
Dollar Volume	96.06
Earnings Date	2026-08-10
EBIT	SAR 1.5M
EBITDA	SAR 3.3M
EPS	SAR 0.54
F Score	6
FCF	SAR 3.8M
FCF EV Yield	6.35x
FCF Per Share	SAR 2.53
Financing CF	-4,308,095
Fiscal Year End	December
Founded	1,986
Graham Number	13.69485
Graham Upside	-57.23
Income Tax	SAR 249,053
Investing CF	-1,968,818
Is Primary Listing	1
Last Earnings Date	2026-02-26
Last Report Date	2025-12-31
Lynch Fair Value	SAR 2.7
Lynch Upside	-91.58
Ma150	31.31
Ma150ch	2.25%
Ma20	31.51
Ma20ch	1.62%
Net CF	-454,573
Next Earnings Date	2026-08-10
Open	32.02
P FCF Ratio	12.74
P OCF Ratio	8.42
Ppne	23,789,286
Price Date	2026-05-07
Price EBITDA	SAR 15.01
Ptbv Ratio	2.1
Relative Volume	0x
Revenue	74,384,311x
Tax By Revenue	0.33x
Tax Rate	23.31%
Tr6m	-7.19%
Volume	3
Z Score	3.08

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TADAWUL/9572 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+5.0%

$1.59 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

Annualized growth of the per-share dividend

Total shareholder yield

+5.0%

Dividend yield + buyback yield combined

Performance

TADAWUL/9572 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TADAWUL/9572?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+58.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

TADAWUL/9572 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

57.2

Neutral momentum band

Price vs 200-day MA

-3.8%

50/200-day relationship not available

Beta (5Y)

0.45

Less volatile than the market

Sharpe ratio

-0.44

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TADAWUL/9572

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tadawul/9572 stock rating?

tadawul/9572 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tadawul/9572 analysis?

The full report lives at /stocks/tadawul/9572/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tadawul/9572?

The latest report frames tadawul/9572 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tadawul/9572 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.